Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial

RATIONALE: The long-acting β(2)-agonist/long-acting muscarinic antagonist combination indacaterol/glycopyrronium (IND/GLY) elicits bronchodilation, improves symptoms, and reduces exacerbations in COPD. Magnetic resonance imaging (MRI) of the lung with hyperpolarized gas and gadolinium contrast enhan...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Wild, Jim M., Saralaya, Dinesh, Lawson, Rod, Marshall, Helen, Goldin, Jonathan, Brown, Matthew S., Kostikas, Konstantinos, Belmore, Kristin, Fogel, Robert, Patalano, Francesco, Drollmann, Anton, Machineni, Surendra, Jones, Ieuan, Yates, Denise, Tillmann, Hanns-Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832861/
https://www.ncbi.nlm.nih.gov/pubmed/35144620
http://dx.doi.org/10.1186/s12931-022-01949-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832861/
https://www.ncbi.nlm.nih.gov/pubmed/35144620
http://dx.doi.org/10.1186/s12931-022-01949-3

Ejemplares similares